Angelman syndrome (AS) is a neurogenetic disorder caused by loss of maternal UBE3A expression or mutation-induced dysfunction of its protein product, the E3 ubiquitin-protein ligase, UBE3A. In humans and rodents, UBE3A/Ube3a transcript is maternally imprinted in several brain regions, but the distribution of native UBE3A/Ube3a 1 protein expression has not been comprehensively examined. To address this, we systematically evaluated Ube3a expression in the brain and peripheral tissues of wild-type (WT) and Ube3a maternal knockout mice (AS mice). Immunoblot and immunohistochemical analyses revealed a marked loss of Ube3a protein in hippocampus, hypothalamus, olfactory bulb, cerebral cortex, striatum, thalamus, midbrain, and cerebellum in AS mice relative to WT littermates. Also, Ube3a expression in heart and liver of AS mice showed greater than the predicted 50% reduction relative to WT mice. Co-localization studies showed Ube3a expression to be primarily neuronal in all brain regions and present in GABAergic interneurons as well as principal neurons. These findings suggest that neuronal function throughout the brain is compromised in AS.
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Introduction
Angelman syndrome (AS) is a neurogenetic disorder associated with profound intellectual disability, severe language impairment, movement and balance disorder, epilepsy, and a unique behavioral profile with frequent laughter and smiling (Williams et al., 2006) . AS results from a deficiency of functional UBE3A (also known as E6-associated protein or E6-AP), an E3 ubiquitin ligase encoded by the UBE3A gene. UBE3A is an imprinted gene, (Knoll et al., 1989; Kishino et al., 1997; Matsuura et al., 1997; Sutcliffe et al., 1997) , and most commonly, AS results from maternal deletions of varying size that include the UBE3A gene. Less common causes of AS are UBE3A mutations, uniparental paternal disomy (UPD), and imprinting center mutations (Laan et al., 1999; Williams et al., 2006) . Although several Ube3a ubiquitination substrates have been described, none have been definitively linked to the pathogenesis of Angelman syndrome (Huibregtse et al., 1991; Kuhne and Banks, 1998; Nuber et al., 1998; Kumar et al., 1999; Reiter et al., 2006; Greer et al., 2010) .
The first AS mouse model developed had partial UPD spanning the region including Ube3a on mouse chromosome 7, the region homologous to human chromosome 15 (Cattanach et al., 1997) . In situ hybridization studies in these mice showed that Ube3a expression was undetectable in the hippocampus and cerebellar Purkinje neurons, suggesting predominant maternal expression in these regions. In other regions including the cerebral cortex, Ube3a expression was moderately reduced, while in regions such as the anterior commissure and optic chiasm, expression was indistinguishable from wild-type (WT) controls, suggesting biallelic Ube3a expression (Albrecht et al., 1997) . A E-mail address: kevin.haas@vanderbilt.edu (K.F. Haas). 1 Throughout the manuscript, following the standard nomenclature, UBE3A and UBE3A will denote the human gene and protein name, respectively, and Ube3a and Ube3a the rodent gene and protein name, respectively. As indicated here, UBE3A and Ube3a are synonymous with E6-AP.
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